Pharmaceuticals, Biotechnology and Life Sciences
Amgen on Tuesday got clearance from the European Commission (EC) for a new single-dose delivery option for its Repatha cardiovascular drug.
Following a diet that mimics fasting may reduce risk factors for disease in generally healthy people, according to a small study.
Studies drug companies fund after medicines go on sale may be too small to detect rare side effects, a recent German study suggests.
Omnicell has bagged a deal with Inova, a not-for-profit healthcare system based in Northern Virginia, for its integrated software and services offering, Performance Center.
The American Brain Tumor Association (ABTA) has elected four new members to its Board of Directors in January, to bring the number of directors to thirteen.
Swedish Orphan Biovitrum (Sobi) has entered into a 3-year agreement with Ireland’s Valeant Pharmaceuticals for the distribution of Ammonul injection, an acute Urea Cycle Disorders (UCDs) drug, in Europe, the Middle East and North Africa.
Botswana will be a centert for southern and east Africa for hematology-oncology treatment, as it will get a new $100…
Nicox, the international ophthalmic R&D company has presented preclinical results from its novel nitric oxide (NO) donating compound, NCX 667 at the Association for Ocular Pharmacology and Therapeutics (AOPT) 13th Scientific Meeting, held from February 16-19, 2017, in Florence, Italy.
Neovacs has signed with BioSense Global a commercial license option agreement for its IFNalpha Kinoid vaccine to treat lupus and dermatomyositis in China, worth up to €65 million in upfront and milestone payments, not including double-digit sales royalties.
Abzena has signed a deal with University College London (UCL) to manufacture Magacizumab, an antibody created with its ‘Abzena inside’ Composite Human Antibody technology.